share_log

广济药业:北京市京师(武汉)律师事务所关于湖北广济药业股份有限公司2021年限制性股票激励计划回购注销部分限制性股票之法律意见书

Guangji Pharmaceutical: Legal opinion from Beijing Jingshi (Wuhan) Law Firm on the repurchase and cancellation of some restricted shares of Hubei Guangji Pharmaceutical Co., Ltd.'s 2021 restricted stock incentive plan

SZSI ·  Nov 9, 2022 11:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more